ETV5 and central nervous system cancer: Aberrant expression of ETV5 during neurodevelopment results in increased gliogenesis (Newton et al., 2018), and targeted expression of ETV5 blocked neural stem cell depletion and tumorigenesis in a mouse model of glioma formation (Breunig et al., 2015).